Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Study compares GLP-1 drug benefits and finds substantial variation in clinical effects

GLP-1 receptor agonists improve glycaemic control and provide renal, metabolic, and selective cardiovascular benefits in people with type 2 diabetes, based on an umbrella review of 17 meta-analyses. However, these agents consistently increase gastrointestinal adverse effects and show important distinctions between class-level outcomes and individual drug effects, particularly for semaglutide.

20 Nov 2025

Global Virus Network awards first pandemic preparedness research grants across four continents

The Global Virus Network (GVN) is pleased to announce that, for the first time, it is awarding pandemic preparedness research grants, totaling $160,000, to GVN scientists across four continents.

20 Nov 2025

Waning immunity and falling vaccination rates fuel pertussis outbreaks

Rates of pertussis, also known as whooping cough, are surging in Texas, Florida, California, Oregon, and other states and localities across the country.

20 Nov 2025

Automated system relies on imaging droplets of biofluids for disease diagnosis

Not long ago, the idea of diagnosing a disease with a droplet of blood was considered a pipe dream. Today, this technology could soon become a reality.

19 Nov 2025

Expert panel recommends new antibiotic strategies for resistant Bordetella pertussis

Pertussis, or whooping cough, remains a highly contagious respiratory infection caused by Bordetella pertussis. Despite inclusion of pertussis vaccines in immunization programs since the 1970s, outbreaks have re-emerged globally due to waning immunity and bacterial evolution.

19 Nov 2025

AI analysis of biopsy slides predicts rectal cancer treatment response

Artificial intelligence (AI) can predict how well patients with rectal cancer will respond to treatment by analyzing standard tissue samples taken during diagnosis, finds a new study from researchers at UCL and UCLH.

19 Nov 2025

Researchers develop new method to combat antibiotic-resistant bacteria using bacteriophages

Antibiotic resistance is one of the most pressing challenges to global public health as harmful microbes evolve to evade these medications.

19 Nov 2025

New AI investment aims to accelerate the search for an effective HIV vaccine

As of 2024, over 40 million people in the world are diagnosed with human immunodeficiency virus (HIV)-a chronic, life-threatening infection that remains one of the leading global causes of death.

18 Nov 2025

Machine learning tool helps evaluate ICU resource efficiency in severe pneumonia care

A study published in the Journal of Critical Care, conducted with the participation of the D'Or Institute for Research and Education (IDOR), investigated how to measure efficiency in the use of resources for patients with severe community-acquired pneumonia (CAP), an illness contracted outside hospital settings and most common among older adults.

18 Nov 2025

Climate extremes continue to drive preventable deaths across the United States

Researchers led by investigators at Mass General Brigham have discovered that over the last 25 years, heat and cold-related deaths have caused more than 69,000 deaths in the U.S., disproportionately affecting certain populations. The findings are published in the Annals of Internal Medicine.

18 Nov 2025

Apriori Bio and A*STAR collaborate to develop next-generation saRNA influenza vaccines

Apriori Bio, a Flagship Pioneering company focused on developing prospective, variant-resilient vaccines, and the Agency for Science, Technology and Research Infectious Diseases Labs (A*STAR IDL) announced a strategic research partnership to co-develop and evaluate next generation self-amplifying RNA (saRNA) vaccines targeting seasonal and pandemic influenza.

18 Nov 2025

Gut immune cells follow an atypical pathway to provide long-lasting antiviral protection

A new study led by University of Toronto researchers has shown that immune cells in the gut follow an atypical pathway to produce antibodies that provide long-term protection against viruses.

17 Nov 2025

Preparing for the respiratory virus season: A guide for families

As respiratory virus season begins, pediatric experts are preparing for an expected rise in cases of Respiratory Syncytial Virus (RSV), which can cause cold-like symptoms in most people but serious illness in infants and older adults.

17 Nov 2025

Wild birds found to be key drivers of H5N1 outbreak in North America

Since late 2021, a panzootic, or "a pandemic in animals," of highly pathogenic bird flu variant H5N1 has devastated wild birds, agriculture, and mammals.

14 Nov 2025

New molecular test revolutionizes fungal infection diagnosis

Certain serious fungal infections occur in regions of the United States with specific environments and are often tied to soil exposure.

14 Nov 2025

Conflicting advice on covid shots likely to ding already low vaccine rates, experts warn

More than three-quarters of American adults didn't get a covid shot last season, a figure that health care experts warn could rise this year amid new U.S. government recommendations.

14 Nov 2025

Machine learning model boosts success of liver transplants from circulatory death donors

There are more candidates on the waitlist for a liver transplant than there are available organs, yet about half the time a match is found with a donor who dies after cardiac arrest following the removal of life support, the transplant must be canceled.

13 Nov 2025

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Study compares GLP-1 drug benefits and finds substantial variation in clinical effects

Global Virus Network awards first pandemic preparedness research grants across four continents

Waning immunity and falling vaccination rates fuel pertussis outbreaks

Automated system relies on imaging droplets of biofluids for disease diagnosis

Expert panel recommends new antibiotic strategies for resistant Bordetella pertussis

AI analysis of biopsy slides predicts rectal cancer treatment response

Researchers develop new method to combat antibiotic-resistant bacteria using bacteriophages

New AI investment aims to accelerate the search for an effective HIV vaccine

Machine learning tool helps evaluate ICU resource efficiency in severe pneumonia care

Climate extremes continue to drive preventable deaths across the United States

Apriori Bio and A*STAR collaborate to develop next-generation saRNA influenza vaccines

Gut immune cells follow an atypical pathway to provide long-lasting antiviral protection

Preparing for the respiratory virus season: A guide for families

Wild birds found to be key drivers of H5N1 outbreak in North America

New molecular test revolutionizes fungal infection diagnosis

Conflicting advice on covid shots likely to ding already low vaccine rates, experts warn

Machine learning model boosts success of liver transplants from circulatory death donors

Age and flu vaccine type influence immune activation

Artificial intelligence improves diagnosis of invisible airway blockages

Tiny airborne plastics may facilitate virus spread

Exploring electron microscopy for plant and microbial imaging at the John Innes Centre

Extending the reach of Amperia™

Modular cleanrooms: Enhancing flexibility and compliance

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Exploring electron microscopy for plant and microbial imaging at the John Innes Centre

Extending the reach of Amperia™

Modular cleanrooms: Enhancing flexibility and compliance

Newsletters you may be interested in